CDH1 and cancer: Chu and co-workers demonstrated, for the first time, that E-cadherin expression is implicated in the molecular response to hypoxia and with the increase of the glycolytic behavior of cancer cells using in vitro and in vivo inflammatory breast cancer models [77].